Lipopolysaccharide (LPS) – Endotoxin & Immune Response
Lipopolysaccharide (LPS) is a key component of the outer membrane of gram-negative bacteria and is a potent activator of the human immune system, playing a central role in infections and inflammatory responses.
Things worth knowing about "Lipopolysaccharide"
Lipopolysaccharide (LPS) is a key component of the outer membrane of gram-negative bacteria and is a potent activator of the human immune system, playing a central role in infections and inflammatory responses.
What is Lipopolysaccharide?
Lipopolysaccharide (LPS), commonly referred to as an endotoxin, is a complex molecule found in the outer membrane of gram-negative bacteria. It is composed of a lipid component (Lipid A), a core polysaccharide, and a variable O-antigen chain. LPS is released when bacteria die or divide and acts as a powerful trigger of the human immune response.
Structure of Lipopolysaccharide
LPS consists of three main structural components:
- Lipid A: The fatty acid-containing anchor embedded in the bacterial membrane. It is the biologically active portion responsible for the toxic properties of LPS and the induction of immune responses.
- Core polysaccharide: A sugar chain linking Lipid A to the outer O-antigen. It is relatively conserved among related bacterial species.
- O-antigen: A highly variable polysaccharide chain that differs between bacterial strains and is used for serotyping and bacterial identification.
Mechanism of Action and Immune Response
When LPS enters the human body, it is recognized as a danger signal by the immune system. The blood protein LPS-binding protein (LBP) captures LPS and presents it to the CD14 receptor on immune cells. This subsequently activates Toll-like receptor 4 (TLR4), triggering a cascade of inflammatory reactions including:
- Release of pro-inflammatory cytokines such as TNF-alpha, interleukin-1 (IL-1), and interleukin-6 (IL-6)
- Activation of macrophages and neutrophils
- Induction of fever
- Vasodilation and increased vascular permeability
In small amounts, this immune response is beneficial for fighting infections. However, when large amounts of LPS are released simultaneously, the response can become dangerously excessive.
Clinical Significance
Sepsis and Septic Shock
One of the most severe consequences of massive LPS release is sepsis (blood poisoning) and, in critical cases, septic shock. This involves an uncontrolled, systemic inflammatory response that can lead to multi-organ failure and death. LPS from gram-negative bacteria is considered a primary trigger of these life-threatening conditions.
Chronic Inflammation
Even chronically elevated, low-grade LPS levels in the bloodstream -- a condition known as metabolic endotoxemia -- have been linked to a range of chronic diseases, including:
- Type 2 diabetes
- Obesity
- Cardiovascular diseases
- Chronic inflammatory bowel diseases
Gut Microbiome and LPS
The gut is a major source of LPS, as it harbors a large population of gram-negative bacteria. A compromised intestinal barrier (often referred to as leaky gut) can allow LPS to enter the bloodstream and promote systemic inflammation. A balanced diet and a healthy gut microbiome may help reduce intestinal LPS translocation.
Diagnostic Relevance
The Limulus Amebocyte Lysate (LAL) test is the gold standard for measuring LPS concentrations in pharmaceutical products, water, and blood samples. The test is based on a clotting reaction derived from the blood of the horseshoe crab, which is highly sensitive to LPS. In clinical settings, LPS measurement can support the diagnosis of gram-negative infections and help assess sepsis risk.
Therapeutic Approaches
Neutralizing or blocking LPS activity is an active area of medical research. Current and investigational therapeutic strategies include:
- Antibiotics: Eliminating gram-negative bacteria to prevent further LPS release
- LPS neutralizers: Substances such as polymyxin B that directly bind and neutralize LPS
- TLR4 antagonists: Compounds that block the LPS receptor and dampen the inflammatory response
- Dietary interventions: Dietary fiber and omega-3 fatty acids may help reduce intestinal LPS translocation and systemic inflammation
References
- Rietschel, E. T. et al. - Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB Journal, 1994.
- Cani, P. D. et al. - Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes, 2007.
- World Health Organization (WHO) - Sepsis Fact Sheet. Available at: https://www.who.int/news-room/fact-sheets/detail/sepsis
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, probiotic lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categorySomnolence
Seborrhoea
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Lipopolysaccharide-en